Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DIBUCAINE 1% OINTMENT

DIBUCAINE
$0.1503per GM
OTC

Strength

10 mg/g

Manufacturer

Rugby Laboratories

NDC

00536121195

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

DIBUCAINE

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M015

On Market Since

8/19/2019

Pharmacological Classes

Allergens
Cell-mediated Immunity
Increased Histamine Release
Standardized Chemical Allergen

Price History

1W

0.0%

1M

+0.1%

3M

-4.1%

6M

-7.9%

1Y

-5.2%

3Y

-10.6%

5Y

+4.5%

All

-9.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GS HEMORRHOIDAL CREAM
Generic
00113094424•L. Perrigo Company
$0.0451
per GM
HEMORRHOIDAL CREAM
Generic
36800094424•Topco Associates LLC
$0.0469
per GM
GLYCERIN SUPPOSITORY
Generic
46122022171•AmerisourceBergen
$0.0689
per EA
HEMORRHOIDAL CREAM
Generic
70000042501•Cardinal Health
$0.0796
per GM
GNP REDNESS RELIEF EYE DROPS
Generic
46122060605•AmerisourceBergen
$0.0947
per ML
REDNESS RELIEF EYE DROPS
Generic
70000001001•Cardinal Health
$0.0947
per ML
FT REDNESS RELIEF EYE DROPS
Generic
70677116101•Strategic Sourcing Services LLC
$0.0947
per ML
GLYCERIN SUPPOSITORY
Generic
46122022163•AmerisourceBergen
$0.1099
per EA
GLYCERIN 2 GM SUPPOSITORY
Generic
57237032552•Rising Pharma Holdings Inc.
$0.1099
per EA
GLYCERIN ADULT SUPPOSITORY
Generic
70000057201•Cardinal Health
$0.1099
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy